PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
26-Aug-2025 Northwell Health Implants Nation’s First Patient with SetPoint System for Treatment of Rheumatoid Arthritis Businesswire
26-Aug-2025 Homecare Clinical Nutrition Market Focused Insights 2025-2030 | Homecare Clinical Nutrition Market to Reach $11.35 Billion by 2030, Fueled by Aging Populations and Increased NCD Prevalence - ResearchAndMarkets.com Businesswire
26-Aug-2025 iXCells Biotechnologies Selected to Perform the First Pilot in Patient-Led ALS Precision Medicine Effort Businesswire
26-Aug-2025 Health Canada Approves MedMira's Reveal(R) Rapid TP Test - Urgent New Tool In The Battle Against Syphilis ACCESS Newswire
26-Aug-2025 Adva Biotechnology and Autolomous Announce Collaboration to Co-Lead the Digital Pioneer Program for Scalable Autologous Cell Therapy Manufacturing Adva Biotechnology
26-Aug-2025 A3 Unveils Expert Lineup for FOCUS: Intelligent Vision & Industrial AI Conference Businesswire
26-Aug-2025 Protagonist Therapeutics to Participate in Multiple Investment Bank Conferences in September 2025 ACCESS Newswire
26-Aug-2025 Altamira Therapeutics to Host First Half 2025 Financial Results and Business Update Call on August 29, 2025 ACCESS Newswire
26-Aug-2025 Sermo Barometer 41 Finds 95% of Global Healthcare Providers Are Concerned About the Upcoming Respiratory Season Businesswire
26-Aug-2025 Cytotoxic Drugs & HPAPI Manufacturing Market Forecast Report to 2035, with Profiles of AbbVie, Cambrex, Catalent, Pfizer CentreOne, Abzena, Aenova, Hovione, Lonza, Scinopharm, Syngene, Teva API & more - ResearchAndMarkets.com Businesswire
26-Aug-2025 Digital Biomarkers Market Trends and Global Forecast Report to 2035, with Profiles of Acculi Labs, ActiGraph, AliveCor, BACtrack, BioSerenity, Empatica, Kontigo Care, Progentec Diagnostics, and more - ResearchAndMarkets.com Businesswire
26-Aug-2025 PannTheraPi prepares plans to conduct its first Phase IIa clinical trial with PTI5803 in patients with resistant epilepsy and accelerate the development of its proprietary pipeline PannTheraPi
26-Aug-2025 Initial Data Shows 100% Disease Control in 5 Out of 5 Patients With Recurrent Glioblastoma With Two Patients in Near Complete Response Treated With ImmunityBio’s ANKTIVA®, NK Cell Therapy Plus Optune Gio® Device Businesswire
26-Aug-2025 Equine Performance Labs Announces Publication of Landmark Study in BMC Medicine Demonstrating Safety, Consistency, and Clinical Promise of equicent™ CTM Umbilical Cord Allograft Businesswire
26-Aug-2025 Harmony Biosciences to Present Rare Epilepsy Data at the 36th International Epilepsy Congress Businesswire
26-Aug-2025 Debiopharm Pushes the Boundaries of Innovation in Antibiotic Development Against Gonorrhea with First-In-Human Debio 1453 Trial Businesswire
26-Aug-2025 Qlaris Bio Announces First Patient Dosed in Phase II Nightingale Clinical Trial in Normal Tension Glaucoma Patients Businesswire
26-Aug-2025 Lineage Announces Research Collaboration With William Demant Invest to Develop ReSonance™ (ANP1) for Hearing Loss Businesswire
26-Aug-2025 Flexential Scales Multichannel Campaigns and Propels Audience Reach by 3X with ON24 AI Capabilities Businesswire
26-Aug-2025 Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced Endometrial Cancer (EC) Businesswire